Guy Cipriani
Chief Operating Officer bei AETHLON MEDICAL, INC.
Vermögen: 3 007 $ am 31.03.2024
Profil
Guy F.
Cipriani is currently the Chief Operating Officer & Senior VP at Aethlon Medical, Inc. He previously worked as the Director of Business Development at TransForm Pharmaceuticals, Inc., a Member of Corporate Business Development at Eli Lilly & Co., the Vice President of Business Development at Correvio Pharma Corp., the Chief Business Officer at Microbion Corp., the Vice President of Business Development at Cascadian Therapeutics LLC, and the Chief Business Officer at Immune Design Corp.
He holds an undergraduate degree from Rochester Institute of Technology and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AETHLON MEDICAL, INC.
0,07% | 30.06.2023 | 1 790 ( 0,07% ) | 3 007 $ | 31.03.2024 |
Aktive Positionen von Guy Cipriani
| Unternehmen | Position | Beginn |
|---|---|---|
| AETHLON MEDICAL, INC. | Chief Operating Officer | 07.11.2023 |
Ehemalige bekannte Positionen von Guy Cipriani
| Unternehmen | Position | Ende |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | 01.07.2017 |
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Corporate Officer/Principal | - |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | - |
Ausbildung von Guy Cipriani
| Rochester Institute of Technology | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| AETHLON MEDICAL, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
